Skip to main content

Baker Douglas P's Form 4 filing

OptimizeRx Corp (OPRX) · filed Sep 9, 2021

Accession no.
0001213900-21-047223
Filed
Sep 9, 2021
Trade date
Sep 7-8, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $829.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Baker Douglas PCIK 0001028775Officer (CHIEF FINANCIAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 7, 2021Common Stock (pursuant to 10B5-1 plan)SSaleDisposed−2,232$70.53−$157,422.9648,564Direct
Sep 8, 2021Common StockMOption exerciseAcquired+10,000$7.51+$75,10058,564Direct
Sep 8, 2021Common Stock (pursuant to 10B5-1 plan)SSaleDisposed−10,000$67.25−$672,50048,564Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 8, 2021Common StockMOption exerciseDisposed−10,000$7.51−$75,10044,699Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)